Clinical trial
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With…
NCT00026663 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00026663 |
|---|---|
| Title | Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance |
| Official title | Collection of Blood, Fluid, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer or Normal Volunteers |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Renal Cell Carcinoma, Lung Carcinoma, Cervical Carcinoma |
| Enrollment | 86 |
| Start date | Aug 9, 2000 |
| Primary completion | Jun 28, 2024 |
| Completion | Jun 28, 2024 |
| First posted | Nov 15, 2001 |
| Last update posted | Jul 1, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: